Screener
Emergent Biosolutions EBS Q1 2025 earnings
Reported May 7, 2025 · After market close
Revenue$222.2MBeat by $3.2M
EPS$0.71Beat by $0.22
Revenue estimate$219.0M
EPS estimate$0.49
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$123.2M
EPS estimate-$0.37
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Emergent Biosolutions report Q1 2025 earnings?
- Emergent Biosolutions (EBS) reported Q1 2025 earnings on May 7, 2025 after market close.
- What were Emergent Biosolutions's Q1 2025 revenue and EPS?
- Emergent Biosolutions reported revenue of $222.2M and eps of $0.71 for Q1 2025.
- Did Emergent Biosolutions beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $219.0M by $3.2M. EPS beat the consensus estimate of $0.49 by $0.22.
- How did Emergent Biosolutions's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 26.0% from $300.4M a year earlier and eps grew 20.3% from $0.59.
- Where can I find Emergent Biosolutions's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001367644-25-000114) and the 10-Q periodic report (0001367644-25-000124) directly on SEC EDGAR. The filing index links above go to sec.gov.
